| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.33T | 607.87B | 622.34B | 821.28B | 822.64B |
| Gross Profit | 616.23B | 749.57B | 1.41T | 821.28B | 822.64B |
| EBITDA | 390.61B | 414.61B | -4.30B | 935.68B | 0.00 |
| Net Income | 330.13B | 335.58B | 332.65B | 324.73B | 302.51B |
Balance Sheet | |||||
| Total Assets | 45.65T | 40.57T | 38.32T | 34.60T | 30.25T |
| Cash, Cash Equivalents and Short-Term Investments | 4.23T | 4.77T | 3.95T | 3.89T | 3.23T |
| Total Debt | 10.08T | 2.87T | 6.61T | 2.00T | 1.62T |
| Total Liabilities | 42.10T | 37.23T | 35.15T | 31.72T | 27.64T |
| Stockholders Equity | 3.52T | 3.32T | 3.01T | 2.86T | 2.59T |
Cash Flow | |||||
| Free Cash Flow | -51.16B | 308.85B | 560.60B | 954.67B | 415.48B |
| Operating Cash Flow | -28.21B | 338.02B | 585.69B | 978.42B | 436.72B |
| Investing Cash Flow | -4.18T | -692.63B | -821.25B | -651.67B | -518.55B |
| Financing Cash Flow | 4.70T | -7.20B | -47.33B | -6.42B | 16.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.16T | 6.94 | 11.95% | 4.26% | -4.57% | 1.77% | |
77 Outperform | HK$2.25T | 5.23 | 9.77% | 5.64% | -4.61% | 0.94% | |
75 Outperform | HK$1.97T | 5.41 | ― | 5.67% | -3.68% | 2.67% | |
71 Outperform | HK$2.61T | 5.58 | 9.18% | 4.81% | -2.85% | 10.49% | |
70 Outperform | HK$2.93T | 5.61 | 9.13% | 5.46% | -3.35% | 0.58% | |
69 Neutral | HK$684.30B | 5.10 | 7.93% | 6.06% | -4.42% | -2.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |